Antibe Therapeutics Inc.

TSX:ATE.TO

0.295 (CAD) • At close April 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 00000000002.7272.952.7932.8651.2292.3472.612.2682.7632.4292.4992.0682.5432.2082.2351.7952.2712.2761.9612.1872.6312.3372.100000000000000
Cost of Revenue 00000000001.6451.911.6181.9430.7161.3881.6561.3281.7261.7261.4651.241.5591.3471.3511.1361.3011.2571.111.2811.4721.3181.06300000000000000
Gross Profit 00000000001.0821.041.1750.9220.5130.9590.9540.941.0370.7041.0340.8280.9840.8610.8840.660.971.0190.8510.9061.1591.0191.03700000000000000
Gross Profit Ratio 00000000000.3970.3530.4210.3220.4170.4090.3660.4140.3750.290.4140.40.3870.390.3960.3670.4270.4480.4340.4140.440.4360.49400000000000000
Reseach & Development Expenses 2.3033.4923.5671.3912.2313.8573.8283.412.4795.2423.2273.1193.4094.8082.0913.1541.6452.3720.9051.3951.0320.4831.0321.1330.5210.4650.6240.160.2060.2320.1020.084-0.0910.2910.1230.2780.2820.7610.9810.4250.5540.1690.080.0680.0650.0650.065
General & Administrative Expenses 2.2121.8612.5662.1352.3642.5351.8742.0172.7153.1213.4012.5412.723.2772.7611.8152.3572.3872.2052.5272.2031.6371.490.5940.9480.8811.5992.0571.7261.3361.3861.7691.3270.450.2390.4220.510.4730.4440.3560.3950.3750.2160.1880.2830.1650.12
Selling & Marketing Expenses 0.0810.0960.1470.0560.0670.1140.0940.0270.040.0260.6730.7850.8840.610.4410.970.9840.8770.960.9370.90.8240.860.9110.7141.0170.3141.3560.0340.030.120.1160.080.0010.005-0.0410.0470.020.0270.0720000000
SG&A 2.2931.9572.7132.1912.4312.6491.9682.0442.7553.1474.0743.3263.6043.8873.2022.7853.3413.2643.1653.4643.1032.4612.351.5051.6621.8981.9133.4141.761.3651.5061.8851.4070.4510.2440.3810.5570.4930.4710.4290.3950.3750.2160.1880.2830.1650.12
Other Expenses 00000000000.0980.1010.1010.1380.1380.1390.140.150.1430.1250.0970.0980.0970.0960.0980.0330.091-0.6640.2960.2890.4760.6110.1990.0160.013-0.0070.0410.0290.1540.0290000000
Operating Expenses 4.5965.4496.283.5824.6626.5065.7965.4545.2348.3897.3996.5467.1148.8335.4316.0785.1265.7864.2134.9844.2323.0423.4792.7342.2812.3962.6282.912.2621.8862.0852.581.5150.7570.380.6520.8811.2831.6060.8820.9490.5440.2960.2550.3480.230.185
Operating Income -4.596-5.449-6.28-3.582-4.662-6.506-5.796-5.454-5.234-8.389-6.317-5.958-5.939-7.911-4.918-6.719-4.172-4.846-3.176-4.281-3.198-2.214-2.495-1.873-1.397-1.736-1.658-1.16-1.696-1.201-0.996-1.394-0.75-0.757-0.38-0.652-0.881-1.283-1.606-0.882-0.949-0.544-0.311-0.276-0.354-0.23-0.185
Operating Income Ratio 0000000000-2.316-2.02-2.126-2.761-4.002-2.863-1.598-2.137-1.149-1.762-1.28-1.071-0.981-0.848-0.625-0.967-0.73-0.509-0.865-0.549-0.379-0.597-0.35700000000000000
Total Other Income Expenses Net 0.383-0.0190.012-0.0070.457-0.059-0.0240.0040-0.020.027-0.4170.007-0.0430.069-1.683-0.031-0.1050.002-0.11-0.103-0.111-0.086-0.04-0.0060.0990.0670.042-0.065-0.018-0.0290.142-0.1380.0020.0010.003000.0060.00600-0.015-0.021-0.005-00
Income Before Tax -4.213-5.006-5.786-3.236-4.205-6.248-5.601-5.286-5.219-8.373-6.299-5.974-5.932-7.954-4.902-6.91-4.203-4.951-3.281-4.391-3.301-2.325-2.664-2.379-1.643-1.863-1.819-2.064-1.696-1.199-1.152-1.613-0.749-0.755-0.379-0.649-0.877-1.276-1.6-0.876-0.949-0.544-0.311-0.276-0.354-0.23-0.185
Income Before Tax Ratio 0000000000-2.31-2.025-2.124-2.776-3.989-2.944-1.61-2.183-1.187-1.808-1.321-1.124-1.048-1.077-0.735-1.038-0.801-0.907-0.865-0.548-0.438-0.69-0.35700000000000000
Income Tax Expense -0-0.4620.002-0.0410.111-0.486-0.0680.054-0.3530.3040.0550.0630.5770.9830.005-0.015-0.0020.0060.0040.0040.0020.131-0.0020.005-0.018-0.176-0.087-0.4440.161-0.037-0.045-0.862-0.003000-0.004-0.008000-0-0.015-0.021-0.00500
Net Income -4.213-5.006-5.786-3.548-4.316-6.079-5.531-5.239-4.849-8.675-6.299-5.974-6.496-8.924-4.907-6.895-4.201-4.957-3.285-4.395-3.303-2.456-2.662-2.384-1.625-1.688-1.733-1.62-1.857-1.162-1.107-0.751-0.746-0.755-0.379-0.649-0.877-1.276-1.6-0.876-0.949-0.544-0.311-0.276-0.354-0.23-0.185
Net Income Ratio 0000000000-2.31-2.025-2.326-3.115-3.993-2.938-1.61-2.186-1.189-1.809-1.322-1.188-1.047-1.08-0.727-0.94-0.763-0.712-0.947-0.531-0.421-0.321-0.35500000000000000
EPS -0.08-0.095-0.11-0.067-0.083-0.12-0.11-0.1-0.094-0.17-0.13-0.15-0.17-0.23-0.16-0.25-0.15-0.19-0.13-0.2-0.15-0.12-0.13-0.16-0.1-0.11-0.15-0.004-0.19-0.12-0.14-0.12-0.1-0.15-0.077-0.002-0.24-0.34-0.44-0.002-0.34-0.2-0.15-0.11-0.14-0.088-0.071
EPS Diluted -0.08-0.095-0.11-0.067-0.083-0.12-0.11-0.1-0.094-0.17-0.13-0.15-0.17-0.23-0.16-0.25-0.15-0.19-0.13-0.2-0.15-0.12-0.13-0.16-0.1-0.11-0.15-0.004-0.19-0.12-0.14-0.002-0.1-0.15-0.077-0.002-0.24-0.34-0.44-0.002-0.34-0.2-0.15-0.11-0.14-0.088-0.071
EBITDA -4.596-4.985-5.796-3.227-4.203-6.187-5.575-5.288-5.159-8.294-6.173-5.393-5.824-7.761-4.772-4.956-3.997-4.676-3.013-4.245-3.094-2.106-2.391-1.773-1.292-1.639-1.565-1.801-1.317-0.893-0.842-1.412-0.469-0.757-0.38-0.649-0.877-1.276-1.6-0.876-0.949-0.544-0.296-0.255-0.348-0.23-0.185
EBITDA Ratio 0000000000-2.264-1.828-2.085-2.709-3.883-2.112-1.531-2.062-1.09-1.748-1.238-1.018-0.94-0.803-0.578-0.913-0.689-0.791-0.672-0.408-0.32-0.604-0.22300000000000000